Streamlining the investigative process - early investigation for thromboembolic and cardiovascular disease in COVID-19 patients.

Early studies regarding COVID-19 have shown increased propensity for thromboembolic[1][1] and cardiovascular[2][2] disease. Prompt identification and treatment may reduce mortality. This project aimed to identify factors that would highlight which patients would benefit from an early computed